BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34918615)

  • 21. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
    Man L; Lv X; Du XD; Yin G; Zhu X; Zhang Y; Soares JC; Yang XN; Chen X; Zhang XY
    Psychiatry Res; 2018 May; 263():1-6. PubMed ID: 29482040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin 18 and cognitive impairment in first episode and drug naïve schizophrenia versus healthy controls.
    Zhang XY; Tang W; Xiu MH; Chen DC; Yang FD; Tan YL; Wang ZR; Zhang F; Liu J; Liu L; Chen Y; Wen N; Kosten TR
    Brain Behav Immun; 2013 Aug; 32():105-11. PubMed ID: 23499732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex differences in the association of body mass index with symptoms and cognitive deficits in Chinese patients with chronic schizophrenia.
    Wei CW; Chen YQ; Ma M; Xiu MH; Zhang XY
    Transl Psychiatry; 2020 Jan; 10(1):18. PubMed ID: 32066717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Tan YL; He S; Kosten TA; Kosten TR
    Schizophr Res; 2013 Feb; 143(2-3):301-6. PubMed ID: 23238053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphism of Transferrin Gene Impacts the Mediating Effects of Psychotic Symptoms on the Relationship between Oxidative Stress and Cognition in Patients with Chronic Schizophrenia.
    Chen P; Wang D; Xiu M; Chen D; Lackey B; Wu HE; Zhou J; Zhang X
    Antioxidants (Basel); 2022 Jan; 11(1):. PubMed ID: 35052629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between the gut microbiota and oxidative stress in the cognitive function of schizophrenia: A pilot study in China.
    Li H; Huang Y; Liang L; Li H; Li S; Feng Y; Feng S; Wu K; Wu F
    Schizophr Res; 2024 May; 267():444-450. PubMed ID: 38643725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma total antioxidant status and cognitive impairments in first-episode drug-naïve patients with schizophrenia.
    Xie T; Li Q; Luo X; Tian L; Wang Z; Tan S; Chen S; Yang G; An H; Yang F; Tan Y
    Cogn Neurodyn; 2019 Aug; 13(4):357-365. PubMed ID: 31354881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated plasma superoxide dismutase in first-episode and drug naive patients with schizophrenia: inverse association with positive symptoms.
    Wu Z; Zhang XY; Wang H; Tang W; Xia Y; Zhang F; Liu J; Fu Y; Hu J; Chen Y; Liu L; Chen DC; Xiu MH; Kosten TR; He J
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):34-8. PubMed ID: 21896300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global functioning, cognitive function, psychopathological symptoms in untreated patients with first-episode schizophrenia: A cross-sectional study.
    Cao X; Chen S; Xu H; Wang Q; Zhang Y; Xie S
    Psychiatry Res; 2022 Jul; 313():114616. PubMed ID: 35576626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage migration inhibitory factor as a potential novel biomarker for cognitive function in patients with first-episode schizophrenia.
    Yu JJ; Zhao Q; Li HN; Song JQ; Chen DC
    Aust N Z J Psychiatry; 2022 Mar; 56(3):292-300. PubMed ID: 33985351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cigarette smoking and cognitive function in Chinese male schizophrenia: a case-control study.
    Zhang XY; Chen DC; Xiu MH; Haile CN; Sun H; Lu L; Kosten TA; Kosten TR
    PLoS One; 2012; 7(5):e36563. PubMed ID: 22570726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased Plasma Levels of Growth Differentiation Factor 11 in Patients With Schizophrenia: Correlation With Psychopathology and Cognition.
    Yang ZX; Zhan JQ; Xiong JW; Wei B; Fu YH; Liu ZP; Tu YT; Yang YJ; Wan AL
    Front Psychiatry; 2020; 11():555133. PubMed ID: 33364986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and Clinical Correlates of and Cognitive Function at the Time of Suicide Attempts in First-Episode and Drug-Naive Patients With Schizophrenia.
    Zhang XY; Du X; Yin G; Zhang Y; Chen D; Xiu M; Wang C; Zhang R; Cassidy RM; Ning Y; Huang X; Soares JC
    J Clin Psychiatry; 2018 Jul; 79(4):. PubMed ID: 30063302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of empathy with clinical symptoms and cognitive function in Chinese chronic schizophrenia patients with and without deficit syndrome.
    Liu J; Tian Y; Wei S; Wang W; Wang D; Zhou H; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Dec; 119():110592. PubMed ID: 35716800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mn-superoxide dismutase activity is associated with orofacial involuntary movements in schizophrenia patients with tardive dyskinesia.
    Wu JQ; Chen DC; Tan YL; Soares JC; Zhang XY
    Hum Psychopharmacol; 2015 Jan; 30(1):57-63. PubMed ID: 25572310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin Resistance and Oxidative Stress: In Relation to Cognitive Function and Psychopathology in Drug-Naïve, First-Episode Drug-Free Schizophrenia.
    Tao Q; Miao Y; Li H; Yuan X; Huang X; Wang Y; Andreassen OA; Fan X; Yang Y; Song X
    Front Psychiatry; 2020; 11():537280. PubMed ID: 33329081
    [No Abstract]   [Full Text] [Related]  

  • 38. Interleukin-3, symptoms and cognitive deficits in first-episode drug-naïve and chronic medicated schizophrenia.
    Xiu MH; Wang D; Chen S; Du XD; Chen DC; Chen N; Wang YC; Yin G; Zhang Y; Tan YL; Cho RY; Soares JC; Zhang XY
    Psychiatry Res; 2018 May; 263():147-153. PubMed ID: 29554544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A ten-year longitudinal repeated assessment study of cognitive improvement in patients with first-episode schizophrenia and healthy controls: The Oslo Schizophrenia Recovery (OSR) study.
    Torgalsbøen AK; Mohn C; Larøi F; Fu S; Czajkowski N
    Schizophr Res; 2023 Oct; 260():92-98. PubMed ID: 37634387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Haile CN; Kosten TA; Kosten TR
    J Clin Psychiatry; 2012 Jul; 73(7):1025-33. PubMed ID: 22901352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.